SPOTLIGHT -
Molnupiravir Shows Promise for Treatment of Moderate COVID-19 in Phase 2/3 Trial
The MOVe-OUT study will continue to the phase 3 portion and evaluate 800 mg of the therapy administered twice daily.
Read More
Efficacy Information May Help Convert COVID-19 Vaccine Doubters
With vaccine uptake slowing, any information that can help is needed to increase administration.
Those With Chronic Lung Disease Have Poorer COVID-19 Outcomes, More Severe Symptoms
Genetic changes enable SARS-CoV-2 to enter the body, replicate and trigger out-of-control immune responses.
Reliable, Non-Invasive Sensor Detects COVID-19 Within a Minute
The biosensor detects fragments of the SARS-CoV-2 virus as well as variants.
Predicting Local COVID-19 Impact With Novel Modelling Toolkit
Understanding how future waves will impact areas can help officials implement policies to mitigate them.
Effect of Pfizer COVID-19 Vaccine on Patients Taking Therapeutic Immunosuppressants
Those taking methotrexate had lower seroconversion rates compared to controls.
FDA to Add Warning Related to Autoimmune Disorder on Johnson & Johnson Vaccine
The CDC announced 100 preliminary cases of Guillain-Barré syndrome following vaccine administration.
Single Dose of Pfizer, AstraZeneca Provides Protection in Older Adults
While infection risk is not eliminated, the vaccine still provided significant protection.
Second COVID-19 Wave Associated With Higher Incidence, Hospital Admissions, Mortality
The second wave in South Africa was larger and saw the Beta lineage dominate.
Test May Help Predict Which COVID-19 Patients at Risk for Heart Complications
Patients who developed atrial fibrillation had higher levels of two known markers of heart stress.
Frequent Testing Helps Prevent Transmission in Schools
Interventions after students receive a positive test were ineffective at preventing more infections.
CDC Updates School Guidelines, Vaccinated Students and Staff Don’t Need Masks
The agency is making the safe return to school in the fall their top priority.
Phase 3 Trial Suggests CoronaVac COVID-19 Vaccine is Safe, Protects Against Disease
The Sinovac developed vaccine could greatly aid in the global inoculation effort.
Research Highlights Importance of full Vaccination, Concerns Around Delta Variant
Two doses of the Pfizer or AstraZeneca vaccines generated high sero-neutralization against the strain.
Pfizer COVID-19 Vaccine Safe, Achieves Serologic Status in Cancer Patients
While the efficacy of SARS-CoV-2 vaccines have been demonstrated, a lack of data is present for patients with cancer.
Low Testosterone Linked With Higher Risk for Severe COVID-19, Death
Research has shown that some receptors for the virus are linked to male hormones.
Outcomes of Hospitalized COVID-19 Patients Improve With Interleukin-6 Antagonists
Patients receiving both IL-6 and corticosteroids showed lower risks of death and mechanical ventilation.
Those Vaccinated Have Reduced COVID-19 Severity, Disease Length and Viral Load
A single dose of mRNA vaccine proved 81% effective against a SARS-CoV-2 infection.
Detecting COVID-19 Infection Increases With Frequent Testing
Testing every 3 days showed a test sensitivity of 98%.
COVAXIN COVID-19 Vaccine Shows Positive Results in Phase 3 Data
The therapy demonstrated an efficacy of 65.2% against the Delta variant.
Johnson & Johnson Vaccine Shows Strong, Persistent Activity Against Delta Variant
The activity was higher than what was recently observed for the South African variant.
Majority of Cancer Patients Respond to COVID-19 Vaccination
94% of the participants in the study developed COVID-19 antibodies.
Novel Malaria Vaccine Shows Strong, Lasting Protection in Phase 1 Trials
At the highest dosage, PfSPZ conferred protection for 3 months.
Immunity to SARS-CoV-2 Lasts Several Months, Potentially Years
Unvaccinated healthcare workers showed similar levels of antibodies to vaccinated ones.
APIC and the Importance of Infection Prevention
A discussion about the Association for Professionals in Infection Control and Epidemiology with CEO Devin Jopp.
Preventing Candida Auris Spread with Surveillance Testing
Screening and isolation protocols were shown to reduce the risk of transmission.
Understanding Challenges of Infection Prevention in Adult Family Homes
AFHs reported concerns such as staff coming to work sick and lack of PPE.
Experience of Infection Preventionists During First Wave of COVID-19
IPs experienced PPE shortages, high levels of stress and emotional exhaustion.
Outcomes of Infection Prevention and Process Measures in Nursing Homes
Staff trainings on prevention practices were found to be common by inconsistent.
Using Retired Infection Preventionists to Address Staffing Shortages
The organizations and their full-time employees both benefited from the PRN IPs.